AF
OM icon

Amalgamated Financial’s Outset Medical OM Stock Holding History

Amalgamated Financial’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$348K Buy
+511
New +$307K ﹤0.01% 1670

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Amalgamated Financial's OM Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Outset Medical (OM) in Q1 2022: 511 shares worth $348K. The stake represents ﹤0.01% of the portfolio and ranks #1670 among its holdings.

152 funds tracked by Wall St. Rank hold OM as of Q1 2022.

  • Amalgamated Financial held 511 shares of Outset Medical worth $348K as of Q1 2022.
  • Outset Medical was a new Amalgamated Financial position in Q1 2022.
  • Outset Medical made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #1670 holding.
  • 152 funds tracked by Wall St. Rank held Outset Medical as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.